All good. The original chat from memory was him explaining that ongoing revenue specifically wouldn't be generated but ongoing annuities instead. I suppose how the money is made is classified differently. The annuities are from the manufacturing of the device. Transcripts from the H124 annual preso:
This is the biggest thing I have repeated in discussions with others here. The whole idea with the device Hologic are developing is 1. A primary FFN test however they plan to add further tests to the device overall.
The device itself is predicated on the existing readers LDX has:
They already have an app for their disposable readers, so you could assume that they may just utilise this existing app platform and alter the interface etc to run the hologic test through the in built display.
